BR0010191A - Determinação de estruturas de fosfolipìdio/lipìdio complexas com auxìlio de acilglicerìdeos marcados com fluorescência sintéticos - Google Patents

Determinação de estruturas de fosfolipìdio/lipìdio complexas com auxìlio de acilglicerìdeos marcados com fluorescência sintéticos

Info

Publication number
BR0010191A
BR0010191A BR0010191-5A BR0010191A BR0010191A BR 0010191 A BR0010191 A BR 0010191A BR 0010191 A BR0010191 A BR 0010191A BR 0010191 A BR0010191 A BR 0010191A
Authority
BR
Brazil
Prior art keywords
acylglycerides
aid
labeled
determination
structures
Prior art date
Application number
BR0010191-5A
Other languages
English (en)
Inventor
Guenter Mueller
Stefan Petry
Holger Jordan
Horst Kleine
Horst Wenzel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0010191A publication Critical patent/BR0010191A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918—Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Patente de Invenção: "DETERMINAçãO DE ESTRUTURAS DE FOSFOLIPìDIO/LIPìDIO COMPLEXAS COM AUXìLIO DE ACILGLICERìDEOS MARCADOS COM FLUORESCêNCIA SINTéTICOS". A invenção refere-se a um teste contínuo simples para a identificação de estruturas, que favorecem a disposição de compostos aromáticos para complexos de transferência de carga, tais com por exemplo, estruturas de fosfolipídio/lipídio complexas (camadas duplas, camadas simples, agregados, micélios) com auxílio de acilglicerídeos marcados com fluorescência sintéticos e sua aplicação para a determinação da atividade de lipases/inibidores de lipases, além disso, um monoacilglicerídeo para a aplicação neste teste e um processo para a sua preparação, bem como o substrato obtido do mesmo e um para a preparação do mesmo.
BR0010191-5A 1999-04-30 2000-04-13 Determinação de estruturas de fosfolipìdio/lipìdio complexas com auxìlio de acilglicerìdeos marcados com fluorescência sintéticos BR0010191A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19919634A DE19919634C2 (de) 1999-04-30 1999-04-30 Test zur Bestimmung der Integrität komplexer Phospholipid/Lipid-Strukturen mit Hilfe synthetischer fluoreszenz-markierter Acylglyceride und dessen Anwendung zur Bestimmung der Aktivität von Lipasen
PCT/EP2000/003308 WO2000067025A1 (de) 1999-04-30 2000-04-13 Bestimmung komplexer phospholipid/lipid-strukturen mit hilfe synthetischer fluoreszenz-markierter acylglyceride

Publications (1)

Publication Number Publication Date
BR0010191A true BR0010191A (pt) 2002-02-13

Family

ID=7906364

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010191-5A BR0010191A (pt) 1999-04-30 2000-04-13 Determinação de estruturas de fosfolipìdio/lipìdio complexas com auxìlio de acilglicerìdeos marcados com fluorescência sintéticos

Country Status (19)

Country Link
US (1) US6783949B1 (pt)
EP (1) EP1177442B1 (pt)
JP (1) JP3712232B2 (pt)
KR (2) KR100723287B1 (pt)
AR (1) AR023778A1 (pt)
AT (1) ATE404868T1 (pt)
AU (1) AU780683B2 (pt)
BR (1) BR0010191A (pt)
CA (2) CA2384394C (pt)
DE (2) DE19919634C2 (pt)
DK (1) DK1177442T3 (pt)
ES (1) ES2310165T3 (pt)
IL (2) IL145919A0 (pt)
MX (1) MXPA01009393A (pt)
NO (1) NO329086B1 (pt)
NZ (1) NZ515085A (pt)
PT (1) PT1177442E (pt)
WO (1) WO2000067025A1 (pt)
ZA (1) ZA200106627B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824334B1 (fr) * 2001-05-03 2003-10-10 Coletica Procede pour tester une substance eventuellement active dans le domaine de la lipolyse et son utilisation principalement cosmetique
US7968306B2 (en) 2002-02-13 2011-06-28 Wisconsin Alumni Research Foundation Method for measuring activity of a specific fraction of albumin
WO2003069305A2 (en) * 2002-02-13 2003-08-21 Wisconsin Alumni Research Foundation Fluorescent phospholipase assay, phospholipase a2 inhibitor and stimulator, and the use thereof
FR2870741B1 (fr) * 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
KR101041808B1 (ko) * 2004-06-01 2011-06-17 엘지전자 주식회사 디엘피 프로젝터의 ｄｍｄ 칩 냉각용 히트싱크의 구조
US20070264670A1 (en) * 2004-07-01 2007-11-15 Dsm Ip Assets B.V. Method for Screening and Selecting Enzymes
WO2006103261A2 (en) * 2005-03-30 2006-10-05 University Of Zürich Inhibitors of neurotrypsin and determination thereof
CN113109479A (zh) * 2021-04-19 2021-07-13 湖北浩华生物技术有限公司 一种高效液相色谱检测三丁酸甘油酯的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI63064C (fi) * 1980-04-09 1983-04-11 Ksv Chemicals Oy Foerfarande foer fluorometrisk bestaemning av aktiviteten av fettspjaelkande enzymer och medel foer att genomfoera foerfarandet
EP0253271B1 (en) * 1986-07-15 1993-06-02 Abbott Laboratories Fluorescence polarization method for monitoring fetal lung maturity

Also Published As

Publication number Publication date
KR20060134224A (ko) 2006-12-27
US6783949B1 (en) 2004-08-31
PT1177442E (pt) 2008-10-15
AU3966100A (en) 2000-11-17
NZ515085A (en) 2004-04-30
IL145919A (en) 2010-06-16
KR100723287B1 (ko) 2007-05-30
NO329086B1 (no) 2010-08-16
KR100770968B1 (ko) 2007-10-30
WO2000067025A1 (de) 2000-11-09
DK1177442T3 (da) 2008-12-08
AU780683B2 (en) 2005-04-14
EP1177442A1 (de) 2002-02-06
ZA200106627B (en) 2002-07-31
ES2310165T3 (es) 2009-01-01
EP1177442B1 (de) 2008-08-13
CA2384394A1 (en) 2000-11-09
DE19919634A1 (de) 2000-11-23
MXPA01009393A (es) 2002-02-25
CA2384394C (en) 2011-11-08
JP3712232B2 (ja) 2005-11-02
JP2002543428A (ja) 2002-12-17
DE50015310D1 (de) 2008-09-25
AR023778A1 (es) 2002-09-04
KR20020022657A (ko) 2002-03-27
NO20015263L (no) 2001-12-19
ATE404868T1 (de) 2008-08-15
IL145919A0 (en) 2002-07-25
CA2742143C (en) 2014-03-18
DE19919634C2 (de) 2001-06-07
CA2742143A1 (en) 2000-11-09
NO20015263D0 (no) 2001-10-26

Similar Documents

Publication Publication Date Title
UY26057A1 (es) Amidas de aminoacidos modificadas, medicamentos que contienen estos compuestos y procedimiento para su preparacion
DE69837678D1 (de) Compositions zur inhibierung der proliferation glatter muskulatur und verfahren zur diagnose von arteriosklerose
ES2181234T3 (es) Producto de combinacion que asocia un acido nucleico a una sustancia que desorganiza la matriz extracelular para la terapia genica.
DE60040335D1 (de) Derivatisierte nukleinsäuren und deren verwendung
DE69636127D1 (de) Multiparameter fluoreszenz in situ hybridisierung
BR0016569A (pt) Processo de isolamento de rna de espécimes de tecido embutidos - parafina fixados - formalina
BRPI9912227A (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
BR9911129B1 (pt) n-alquiluretanos (i) de fructanos, seu uso, bem como sua composiÇço e processo para sua produÇço.
PT1129212E (pt) Processo de triagem para agentes antibacterianos
WO2005010215A3 (en) Methods for identifying tolerance modulatory compounds and uses therefor
BR0010191A (pt) Determinação de estruturas de fosfolipìdio/lipìdio complexas com auxìlio de acilglicerìdeos marcados com fluorescência sintéticos
ATE212065T1 (de) Nukleinsäuremoleküle mit der fähigkeit zur unterscheidung von prpc und prpsc-prionprotein- isoformen und verfahren zu deren herstellung
FI953990A (fi) Menetelmä nukleiinihappomonistusreaktiotuotteen tekemiseksi kykenemät-tömäksi olemaan lisämonistuksen kohteena, diagnostinen määritysmenetelmä, jossa tätä menetelmää käytetään, ja menetelmän tai määrityksen toteutukseen sopiva testipakkaus ja säiliö
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
WO2003085374A3 (en) Multiplexed assays using electrophoretically separated molecular tags
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
ATE474047T1 (de) Nukleinsäuremolekül, die für die alpha-kettedes pferde-fc-epsilon-rezeptors kodieren, korrespondierende proteine und ihre verwendungen
BR0312944A (pt) Oligonucleotìdeos para detecção de microorganismos
WO2004087070A3 (en) METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-FUNGAL AGENTS
ATE256120T1 (de) Reagentien für cyp2d fluoreszenztest
Ingram et al. 8-hydroxyquinolinyl azo dyes: a class of surface-enhanced resonance Raman scattering-based probes for ultrasensitive monitoring of enzymatic activity
ATE332916T1 (de) Farbstoff-markiertes peptid und dessen verwendung zur diagnostik
WO2001004354A3 (en) Use of ras inhibitors of inhibiting muscle atrophy
BR0106880A (pt) Tubulação metálica revestida com um polìmero termoplástico para o transporte de produtos de petróleo, e, processo para revestir uma tubulação metálica com uma camisa termoplástica

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 13, 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.